Riskpilot← Back to searchSign inGet full accessIDEX BIOMETRICS ASA
ASAActiveOrg 976846923Henrik Ibsens Gate 90, 0255 OsloManufacture of instruments and appliances for measuring, testing and navigation · NACE 2651Est. 19962 employeeswww.idexbiometrics.com
Revenue 2024
NOK 793K
-81% vs 2023
EBITDA margin
-2866.3%
+8% vs 2023
Equity ratio
5.6%
Financial strength
Net profit 2024
NOK -23M
+9% vs 2023
| Revenue | NOK 793K | -81% |
| EBITDA | NOK -22,7M | +8% |
| Net profit | NOK -23M | +9% |
| Total assets | NOK 11,9M | -65% |
| Equity | NOK 666K | -96% |
| Employees | 2 | — |
Legal name
IDEX BIOMETRICS ASA
Org number
976846923
Legal form
Allmennaksjeselskap
NACE code
2651 · Manufacture of instruments and appliances for measuring, testing and navigation
Founded
24. juli 1996
Share capital
NOK 65 011 963
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap eller daglig leder og styrets leder i fellesskap.
Company purpose
Levere identifikasjonssystemer og drive annen virksomhet knyttet til dette.
Address
Henrik Ibsens Gate 90, 0255 Oslo
Website
www.idexbiometrics.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 095 | 2 840 | 4 091 | 4 138 | 793 |
| Staff expenses | −2 831 | −4 038 | −2 906 | −2 308 | −1 087 |
| EBITDA | −16 589 | −37 135 | −29 081 | −24 719 | −22 730 |
| Depreciation & amort. | −519 | −600 | −599 | −752 | −1 751 |
| EBIT | −17 108 | −37 735 | −29 680 | −25 471 | −24 481 |
| Net financials | −129 | −1 154 | −1 344 | 330 | 1 505 |
| Profit before tax | −17 237 | −38 889 | −31 024 | −25 141 | −22 976 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −17 237 | −38 889 | −31 024 | −25 141 | −22 976 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 25 050 | 44 795 | 33 304 | 33 701 | 11 894 |
| Equity | 20 576 | 39 431 | 25 505 | 15 922 | 666 |
| Long-term debt | 14 | 0 | 0 | 0 | 2 123 |
| Short-term debt | 4 460 | 5 364 | 7 799 | 17 779 | 9 105 |
| Total debt | 4 474 | 5 364 | 7 799 | 17 779 | 11 228 |
EBITDA margin
-2866.3%
This company
15.8%
Market median
-18241% vs market
20202024
Equity ratio
5.6%
This company
38.2%
Market median
-85% vs market
20202024
Return on equity
-3449.8%
This company
18.4%
Market median
-18849% vs market
20202024
Net profit margin
-2897.4%
This company
8.1%
Market median
-35870% vs market
20202024
Asset turnover
0.07×
This company
1.12×
Market median
-94% vs market
20202024
Debt / equity
16.86×
This company
0.62×
Market median
-2619% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AS Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (2) | ||
VA Chief Executive Officer | Chief Executive Officer | 2020 – 2025 |
UC Chief Executive Officer | Chief Executive Officer | 2025 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2024 | |
| Board of Directors | 2021 | |
| Board of Directors | 2023 | |
| Former (5) | ||
| Board of Directors | 2021 – 2023 | |
| Chairman | 2023 – 2024 | |
| Board of Directors | 2021 – 2024 | |
| Board of Directors | 2021 – 2024 | |
| Board of Directors | 2021 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
The Bank Of New York Mellon | Company | 10.82% | 10.82% | 2024 |
| Company | 8.1% | 8.1% | 2024 | |
| Individual | 7.72% | 7.72% | 2023 | |
| Company | 4.76% | 4.76% | 2024 | |
| Individual | 4.69% | 4.69% | 2022 | |
| Company | 4.48% | 4.48% | 2024 | |
| Individual | 4% | 4% | 2022 | |
Bank Pictet & Cie (Europe) Ag | Company | 3.9% | 3.9% | 2023 |
| Individual | 3.86% | 3.86% | 2022 | |
| Individual | 3.83% | 3.83% | 2022 | |
Bank Pictet & Cie (Europe) Ag | Company | 3.73% | 3.73% | 2024 |
| Individual | 3.34% | 3.34% | 2022 | |
| Company | 2.6% | 2.6% | 2024 | |
| Company | 2% | 2% | 2024 | |
| Company | 1.94% | 1.94% | 2024 | |
| Company | 1.59% | 1.59% | 2023 | |
| Individual | 1.5% | 1.5% | 2022 | |
Dnb Bank Asa | Company | 1.42% | 1.42% | 2024 |
| Company | 1.39% | 1.39% | 2024 | |
| Individual | 1.29% | 1.29% | 2022 | |
| Individual | 1.28% | 1.28% | 2022 | |
| Company | 1.23% | 1.23% | 2024 | |
| Company | 1.15% | 1.15% | 2024 | |
Avanza Bank Ab | Company | 1.1% | 1.1% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of IDEX BIOMETRICS ASA also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Storbråten | Chief Executive Officer | 0 companies |
| Vincent Arthur Graziani | Chief Executive Officer | 0 companies |
| Ulrika Catharina Eklöf | Chief Executive Officer | 0 companies |
| Morten Opstad | Chairman | 0 companies |
| Hanne Høvding | Board of Directors | 0 companies |
| Lawrence John Ciaccia | Chairman | 0 companies |
| Annika Olsson Roth | Board of Directors | 0 companies |
| Deborah Lee Davis | Board of Directors | 0 companies |
| Adriana Saitta | Board of Directors | 0 companies |
| Stephen Andrew Skaggs | Board of Directors | 0 companies |
| Thomas Michael Quindlen | Board of Directors | 0 companies |